Breast cancer drug improves outcomes for some bladder cancer patients

[News]

Researchers at Mayo Clinic have found amplification of HER2, a known driver of some breast cancers, in a type of bladder cancer called micropapillary urothelial carcinoma (MPUC) and have shown that the presence of HER2 amplification is associated with particularly aggressive tumors.

More... (http://www.medicalnewstoday.com/releases/271585.php)